For Your Patients

• • For Your Patients
  Neurologists See Some Gains in CMS' 2014 Fee Schedule
• • For Your Patients
  Why Neurointensivists Are Rethinking the Prehospital Hypothermia Protocol After Cardiac Arrest
• • For Your Patients
  FDA to 23andMe: ‘Stop Marketing Genetic Tests’
• • For Your Patients
  New AAN Guideline: The Evidence for Screening and Treating Psychiatric Disorders in MS
• • For Your Patients
  FROM THE AMERICAN HEADACHE SOCIETY: ‘Choosing Wisely’: 5 Things Neurologists and Patients Should Question about Migraine
• • For Your Patients
  What Does FDA's ‘Breakthrough’ Pathway Mean for Neurology?
• • For Your Patients
  Meningitis B Outbreaks Prompt Different Emergency Responses
• • For Your Patients
  Nearly One-Third of Large Clinical Trials Go Unpublished — in Neurology, Too
• • For Your Patients
  NEWS FROM THE SOCIETY FOR NEUROSCIENCE ANNUAL MEETING: An Early Report: APOE Modifier for Alzheimer's Could Be Ready for Human Trials
• • For Your Patients
  TUNE IN, JOIN IN THE DIALOGUE: How do metabolic syndrome and time spent in the ICU contribute to cognitive decline?